South San Francisco, CA, United States of America

Joy Drobnick

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 11.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2016 - 2022)
  • Daly City, CA (US) (2019 - 2023)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Joy Drobnick - Innovator in Isoquinoline Compounds

Introduction

Joy Drobnick is an accomplished inventor based in South San Francisco, California, with an impressive portfolio of 10 patents. Her work primarily focuses on isoquinoline compounds and their diverse applications, showcasing her significant contributions to the field of medicinal chemistry.

Latest Patents

Among her latest innovations are two notable patents. The first patent revolves around isoquinoline compounds of formula (I), which have been identified as useful inhibitors of HPK1 (hematopoietic kinase 1). These compounds hold potential in treating HPK1-dependent disorders and enhancing the immune response. Additionally, her patent outlines various methods for inhibiting HPK1, treating related disorders, and preparing these isoquinoline compounds.

In her second patent, Joy explores 3-carbonylamino-8-aminoisoquinoline compounds of formula (I). Similar to the previous invention, these compounds are also recognized as inhibitors of HPK1 and are aimed at treating HPK1-dependent disorders. The patent includes methods for inhibiting HPK1, enhancing immune responses, and preparing these innovative compounds.

Career Highlights

Joy is currently associated with Genentech, Inc., where she utilizes her expertise in pharmaceutical research and development. Her dedication to advancing medical therapies through innovative compound discovery underscores her commitment to improving health outcomes.

Collaborations

Throughout her career, Joy has worked alongside notable colleagues, including Naomi S. Rajapaksa and Jun Liang. Their collaborative efforts foster a creative environment that enhances the research impact and accelerates the development of ground-breaking therapies.

Conclusion

Joy Drobnick's innovations in isoquinoline compounds not only reflect her expertise as an inventor but also emphasize the importance of collaborative research in the medical field. With ten patents to her name, Joy continues to pave the way for advancements in treating HPK1-dependent disorders, highlighting her role as a key contributor to modern pharmacological science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…